This session will include five short presentations, followed by a questions and answers period. 

• Alzheimer’s disease biomarker testing in routine medical care in Canada substantially changes clinical management: Findings from the IMPACT-AD BC study / Mari DeMarco
• Understanding and improving the care of men and women with dementia across four Canadian provinces during and after the COVID-19 pandemic / Genevieve    Arsenault-Lapierre
• Development of a remotely-delivered culturally safe support group for Indigenous caregivers of persons living with dementia / Megan O'Connell
• Launching the Driving and Dementia Roadmap: Past, Present and Future / Gary Naglie
• Management of apathy: Evidence-based non-pharmacological and pharmacological approaches / Shankar Tumati